1-3 of 3
Joannis Mytilineos, MD
Close
Sort by
Journal Articles

Classification of Donor KIR-Genotype Information to Predict Outcome after Unrelated Hematopoietic Stell Cell Transplantation: The Jury Is Still out

Johannes Schetelig, MDMSc, Henning Baldauf, Carolin Massalski, Sandra Frank, Jürgen Sauter, Matthias Stelljes, MD, Francis A. Ayuk, MD, Armin Gerbitz, MD, Wolfgang Bethge, MD, Gesine Bug, Stefan A Klein, MD, Sarah Wendler, MSc, Falk Heidenreich, Julia Luedemann, Vinzenz Lange, PhD, Liesbeth C. de Wreede, PhD, Daniel Fürst, MD PhD, Alexander H. Schmidt, Guido Kobbe, Hellmut Dietmar Ottinger, MD PhD, Carlheinz Mueller, Dietrich W. Beelen, Joannis Mytilineos, MD PhD, Katharina Fleischhauer, Martin Bornhäuser, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2162.
https://doi.org/10.1182/blood-2018-99-111242
Published: 2018
Journal Articles

The Role of HLA-E Polymorphism in Acute Leukemia Patients Receiving a 10/10 HLA Matched Unrelated HSCT

Chrysanthi Tsamadou, MD, Tao Wang, PhD, Daniel Fürst, MD PhD, Stephanie J. Lee, MD MPH, Stephen R. Spellman, Katharina Fleischhauer, Katharine C. Hsu, MD PhD, Sophie Paczesny, MD PhD, Michael R Verneris, MD, Christine Neuchel, PhD, Hubert Schrezenmeier, MD, Joannis Mytilineos, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 310.
https://doi.org/10.1182/blood-2018-99-113432
Published: 2018
Journal Articles

Polymorphisms of the Transforming Growth Factor Beta 1 (TGFB1) Gene Define a Subgroup of Patients with Late Onset of Disease and Poor Outcome in Multiple Myeloma.

Kai Neben, MD, Joannis Mytilineos, MD, Christiane Heiss, Anthony D. Ho, MD, Axel Benner, Gerhard Opelz, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2007) 110 (11): 1491.
https://doi.org/10.1182/blood.V110.11.1491.1491
Published: 2007